- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced Unresectable or Metastatic Solid Tumors in New Zealand
Total 830 results
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsCanada, United States, Spain, France, Switzerland
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
Multitude Therapeutics (Australia) Pty LtdRecruiting
-
Repare TherapeuticsRoche Pharma AGRecruitingAdvanced Solid Tumor, AdultUnited States
-
Erasca, Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States, Korea, Republic of, Canada, United Kingdom, Australia
-
Xilio Development, Inc.Recruiting
-
LaNova Australia Pty LimitedRecruitingAdvanced Solid TumorAustralia
-
Centessa Pharmaceuticals (UK) LimitedLockBody Therapeutics LtdRecruitingAdvanced Solid TumorUnited States, France
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Agenus Inc.Active, not recruiting
-
Xilio Development, Inc.Active, not recruiting
-
Synnovation Therapeutics, Inc.Recruiting
-
Zai Biopharmaceutical (Suzhou) Co., Ltd.Completed
-
Roswell Park Cancer InstituteUnited States Department of DefenseRecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastroesophageal Junction Adenocarcinoma | Unresectable Gastroesophageal Junction Adenocarcinoma | Locally Advanced Gastroesophageal Junction... and other conditionsUnited States
-
SelecxineRecruitingAdvanced Solid TumorUnited States, Australia, Korea, Republic of
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan
-
Cullinan Oncology Inc.Harbour BioMed US, Inc.Recruiting
-
Gilead SciencesRecruitingAdvanced Solid TumorUnited States, Australia, Taiwan, Spain, Canada
-
U3 Pharma GmbHCompletedAdvanced Solid TumorsUnited States
-
Eucure (Beijing) Biopharma Co., LtdRecruitingAdvanced Solid TumorChina, Australia
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
Werewolf Therapeutics, Inc.RecruitingNon-Hodgkin Lymphoma | Advanced or Metastatic Solid TumorsUnited States
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan
-
SpringWorks Therapeutics, Inc.Recruiting
-
Fujifilm Pharmaceuticals U.S.A., Inc.Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorUnited States
-
Sermonix Pharmaceuticals Inc.Linical Accelovance GroupActive, not recruitingLocally Advanced or Metastatic Breast CancerUnited States, Canada, Israel
-
Cullinan Therapeutics Inc.RecruitingAdvanced Solid TumorUnited States, Spain, Australia, Poland
-
Columbia UniversityGenentech, Inc.RecruitingAdvanced Solid Tumor | Immune-related Adverse EventsUnited States
-
Harbour BioMed US, Inc.CompletedAdvanced Solid TumorAustralia, China, Hong Kong
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
BicycleTx LimitedRecruitingAdvanced Solid TumorUnited States, United Kingdom
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorAustralia, United States
-
MedImmune LLCActive, not recruitingSelected Advanced Solid TumorsItaly, Spain, United States, France, Korea, Republic of, Taiwan, Australia, Netherlands, Portugal
-
QSAM Therapeutics, Inc.RecruitingBone Cancer | Solid Tumor | Bone Tumor | Metastatic Cancer to the Bone | Metastatic Tumor to the BoneUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingLocally Advanced Leiomyosarcoma | Metastatic Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Leiomyosarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
ImaginAb, Inc.CompletedMetastatic Solid Tumors | Positron-Emission TomographyUnited States
-
Eisai Inc.Completed
-
Repare TherapeuticsActive, not recruitingAdvanced Solid TumorUnited States, Canada, Spain, United Kingdom
-
Triumvira Immunologics, Inc.RecruitingMetastatic Solid TumorUnited States, Canada
-
Changchun Intellicrown Pharmaceutical Co. LTDCovanceRecruitingAdvanced EGFR Positive Solid TumorUnited States, China
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid TumorUnited States, Canada, Denmark, United Kingdom
-
Gilead SciencesActive, not recruitingMetastatic Solid TumorUnited States, Spain, France, Hong Kong, Australia, Belgium, Taiwan, Canada
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; Genentech, Inc.; Ohio State University; TargosActive, not recruitingUrothelial Carcinoma | Locally Advanced | UnresectableUnited States
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States